… ) for ACS in the contemporary setting of antiplatelet treatment with clopidogrel and the novel
… the incidence of coronary heart disease risk factors, prior MI, coronary artery bypass grafting, …

… Finally, in stable coronary artery disease, the only P2Y 12 blocker currently indicated for
patients undergoing elective PCI is clopidogrel, which requires several hours to reach full …

… Although there were no significant differences for the primary analysis, in a prespecified
subgroup of 12, 153 patients with a prior history of cardiovascular disease, clopidogrel therapy …

… Coronary artery bypass graft (CABG) surgery is widely used to relieve symptoms and improve
prognosis in patients with complex coronary artery disease (… resistance to clopidogrel 69 . …

… Since then, CABG has been established as an effective treatment for coronary artery disease
(CAD) not responding to pharmacological treatment, and is currently the preferred modality …

… a significant decrease in the early use of prasugrel and clopidogrel (13.3% to 11.9% and …
over clopidogrel included younger age, white race, HMO/private insurance, home ticagrelor use…

… , peripheral artery disease, prior myocardial infarction, prior percutaneous coronary
intervention, prior coronary artery … in ACS patients [15,16], clopidogrel is still widely used in daily …

… However, its definitive role in contemporary practice is yet to … (EMA) [9] for use in patients
with coronary artery disease (CAD) … , dose and timing of clopidogrel loading, and duration of …

… , and most modern series exclude SCAD due to atherosclerotic coronary artery disease. For
… Clopidogrel for acute management of SCAD patients not treated with stents is of uncertain …

… , the use of aspirin, … contemporary study of patients undergoing peripheral revascularization,
a subgroup at heightened risk for cardiovascular and limb ischemic outcomes, reported use …